Aerovate Therapeutics (AVTE)
(Real Time Quote from BATS)
$19.96 USD
-0.21 (-1.04%)
Updated May 21, 2024 01:50 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (88 out of 248)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.74 | 7.43 | 57.00 |
Year Ago Quarter Estimate | -0.76 | 0.12 | 52.54 |
Next Quarter Estimate | -0.67 | 7.81 | 61.00 |
Next Year Estimate | -2.71 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -2.44 | 14.90 | 15.67 |
Next Year | 7.82 | 8.30 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 6.38 | 2.31 |
Price/Cash Flow (MRFY) | NA | 17.10 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -153.43% |
Return on Equity (TTM) | -70.24% | -58.74% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.